Clinical course of COVID-19 patients treated with ECMO: A multicenter study in Daegu, South Korea

Abstract

BackgroundThe COVID-19 pandemic has caused an epidemic of critical patients, some of whom have been treated with extracorporeal membrane oxygenation (ECMO). This purpose of study is to describe the clinical course of COVID-19 patients treated with ECMO. MethodsA multicentered study of critical patients with COVID-19 treated at six hospitals in Daegu was conducted between January and April 2020. ResultsAmong the 80 patients receiving mechanical ventilation support, 19 (24%) were treated with ECMO included (median age 63.0 years). Eight of the 19 patients (42%) were weaned off ECMO (9.8 days, IQR 7.0-13.7). Among them, four patients were also weaned off mechanical ventilation (33.4 days, IQR 29.3 - 35.7), three were still receiving mechanical ventilation (50.9 days), and one expired after ECMO weaning. According to the univariate analysis, the factor that was associated with successful ECMO weaning was vitamin B12 treatment (p = 0.028). ConclusionsDuring the COVID-19 epidemic, ECMO weaning and mortality rates were 42% and 58%, respectively.